Axovant Sciences Ltd. | Balance Sheet
Fiscal year is April-March. All values USD Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
-
276,251.00
212,573.00
154,337.00
Total Accounts Receivable
-
970.00
658.00
1,751.00
Other Current Assets
3.60
4,865.00
6,457.00
2,174.00
Total Current Assets
3.60
282,086.00
219,688.00
158,262.00
Net Property, Plant & Equipment
9.10
89.00
142.00
2,524.00
Other Assets
1,104.70
-
-
-
Total Assets
1,117.40
282,498.00
222,539.00
160,786.00
ST Debt & Current Portion LT Debt
-
-
-
9,753.00
Other Current Liabilities
3,868.20
15,755.00
46,266.00
36,822.00
Total Current Liabilities
3,868.20
15,755.00
46,266.00
46,575.00
Long-Term Debt
-
-
51,436.00
42,925.00
Deferred Taxes
-
323.00
2,709.00
-
Other Liabilities
5,000.00
-
-
-
Total Liabilities
8,868.20
15,755.00
97,702.00
89,500.00
Common Equity (Total)
7,750.80
266,743.00
124,837.00
71,286.00
Total Shareholders' Equity
7,750.80
266,743.00
124,837.00
71,286.00
Total Equity
7,750.80
266,743.00
124,837.00
71,286.00
Liabilities & Shareholders' Equity
1,117.40
282,498.00
222,539.00
160,786.00
About Axovant Sciences
View Profile
